FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
FDA approves marketing of nicotine pouches
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches—small synthetic fiber pouches containing nicotine—are designed to be placed between a person's gum and lip.
VELO x Lab54 presents the VELO [A]PRÈS PARTY, a series of winter parties launching in major UK cities — for your chance to ...
Despite persistent regulatory uncertainty and declining cigarette usage worldwide, the tobacco industry is alive and well in ...
Survey data from over 2,100 15-18 year olds gathered by drug education charity the DSM Foundation has shown that 46 per cent of respondents say that nicotine pouches – often referred to as “snus” – ...
Nicotine pouch use grew in popularity during the survey period, as 24.7% of soldiers queried in 2023 reported using nicotine pouches compared with 20.2% in 2022.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback